4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-002962
Chief Executive Officer acquired 299,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-20 | Grant or award | +299,800 | 893,310 | D | ||
| Derivatives | |||||||
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-20 | Grant or award · Employee Stock Option (right to buy) | +450,000 | 450,000 | D | ||
Loading xslF345X05/wk-form4_1769038356.xml…